Neal Shore, MD of Carolina Urologic Research Center @UNCurology discusses DARolutamide observationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients.
Read her: https://meetinglibrary.asco.org/record/191738/abstract
Advertisement